Mona Ranade: Insights from a Medeloop Analytics Study Evaluate Catheter-Directed Therapy in Pulmonary Embolism
Mona Ranade, Clinical Associate Professor at Stanford University, shared on LinkedIn:
”If you’re interested in how real-world data can actually change the way we think about clinical care, this is worth a watch.
In this walkthrough, Mira M. breaks down our study on catheter-directed therapy for pulmonary embolism – from how we built the cohort to what the results really mean in practice.
She does an incredible job showing not just the findings (earlier CDT – lower 90-day costs driven by less downstream utilization), but how we were able to get there using Medeloop Analytics.
This is what stood out to me: the ability to go from a clinical question to a longitudinal, meaningful answer – fast.
And if you’ve been following along – Medeloop Health Research Case Competition wraps up May 7th at 12 PM, where winners will be announced.
Excited to see what others have built – this is just the beginning of what this kind of tooling makes possible.”
Stay updated with Hemostasis Today.
-
Jun 29, 2026, 03:10Aryabhatta Sadhu: ABO and Rh Incompatibility In Stem Cell Transplantation
-
Jun 29, 2026, 02:41Arun V. J.: ISBT Is Where the Future of Transfusion Medicine Begins
-
Jun 29, 2026, 02:41Manish Raturi: Does Patient Type Matter in Massive Blood Transfusion?
-
Jun 29, 2026, 02:25Hortense Ngegni: From Poster Presentation to Global Connections at ISBT 2026
-
Jun 29, 2026, 01:19Peter Jaworski: Grateful to Win the 2026 Plasma Hero Award at Immune Deficiency Foundation Conference
-
Jun 29, 2026, 01:11Gerrit M. Grosse: Mapping the Landscape of Biomarkers in Post-Stroke Cognitive Impairment
-
Jun 29, 2026, 01:07Katerina Pavenski: Key Insights on Patient Blood Management at ISBT 2026
-
Jun 28, 2026, 19:05Jack Shuang Hou: Novo Nordisk to Present New Haemophilia Data on Investigational Denecimig at ISTH 2026
-
Jun 28, 2026, 19:05Pinar Demirtepe: Not All “Blood Thinners” Are the Same